Intralesional increase of TEM count is well described, predominantly in solid malignancies, but although specific chemoattraction by ANG2 has been demonstrated in vitro as well as in vivo, the detailed contribution of TEMs from compartments outside a tumor (spleen, peripheral blood) is still uncertain [22, 38]. This evidence concerns the gene ANGPT2 and neoplasm.